Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Net Cash Flow (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Net Cash Flow for 16 consecutive years, with $53824.0 as the latest value for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 85.19% to $53824.0 in Q4 2025 year-over-year; TTM through Nov 2025 was -$241929.0, a 256.19% decrease, with the full-year FY2025 number at -$241929.0, down 256.19% from a year prior.
  • Net Cash Flow was $53824.0 for Q4 2025 at Cryo Cell International, down from $127716.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $916686.0 in Q1 2021 to a low of -$6.1 million in Q1 2022.
  • A 5-year average of -$502104.7 and a median of -$168442.0 in 2023 define the central range for Net Cash Flow.
  • Peak YoY movement for Net Cash Flow: plummeted 84912.58% in 2021, then skyrocketed 304.31% in 2024.
  • Cryo Cell International's Net Cash Flow stood at $562282.0 in 2021, then tumbled by 317.1% to -$1.2 million in 2022, then soared by 85.42% to -$177929.0 in 2023, then surged by 304.31% to $363523.0 in 2024, then tumbled by 85.19% to $53824.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Net Cash Flow are $53824.0 (Q4 2025), $127716.0 (Q3 2025), and -$85631.0 (Q2 2025).